# Principia Biopharma Inc.

Principia Biopharma Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** Principia Biopharma Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001510487

## About

Principia Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001510487, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-10, it reported annual revenue of USD 35,160,000; total assets of USD 382,736,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $35.2M (USD 35,160,000)
- **Total assets:** $382.7M (USD 382,736,000)
- **Cash and equivalents:** $39.5M (USD 39,537,000)
- **Operating cash flow:** -$42.5M (USD -42,546,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $69.1M (USD 69,137,000)
- **Net income:** $18.2M (USD 18,167,000)
- **Total assets:** $195.5M (USD 195,521,000)
- **Cash and equivalents:** $34.5M (USD 34,489,000)
- **Operating cash flow:** -$21.2M (USD -21,173,000)

## Recent SEC filings

- Form 8-K — filed 2020-09-28 — period 2020-09-28 — 8-K
- Form SC 13D — filed 2020-08-25 — THE SCHEDULE 13D
- Form SC 13G — filed 2020-08-19 — THE SCHEDULE 13G
- Form 8-K — filed 2020-08-17 — period 2020-08-16 — 8-K
- Form 10-Q — filed 2020-08-06 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-08-06 — period 2020-08-06 — 8-K
- Form 8-K — filed 2020-06-26 — period 2020-06-22 — 8-K
- Form 8-K — filed 2020-06-12 — period 2020-06-12 — 8-K
- Form 8-K — filed 2020-06-09 — period 2020-06-04 — 8-K
- Form 10-Q — filed 2020-05-06 — period 2020-03-31 — 10-Q
- Form 8-K — filed 2020-05-06 — period 2020-05-06 — 8-K
- Form DEF 14A — filed 2020-04-24 — period 2020-06-04 — DEF 14A

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/principia-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology